AstraZeneca and Sanofi’s Breakthrough RSV Infant Shots Approved in China
-
Drug News
AstraZeneca and Sanofi’s Breakthrough RSV Infant Shots Approved in China
In a significant development for infant healthcare, AstraZeneca and Sanofi have announced the approval of their respiratory syncytial virus (RSV)…
Read More »